Pediatrix Medical Group (MD) Competitors $13.78 0.00 (0.00%) Closing price 07/3/2025 03:30 PM EasternExtended Trading$13.78 0.00 (-0.04%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MD vs. AMED, AMN, CCRN, LH, DGX, DVA, CHE, CRVL, BLCO, and BTSGShould you be buying Pediatrix Medical Group stock or one of its competitors? The main competitors of Pediatrix Medical Group include Amedisys (AMED), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Labcorp (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Bausch + Lomb (BLCO), and BrightSpring Health Services (BTSG). Pediatrix Medical Group vs. Its Competitors Amedisys AMN Healthcare Services Cross Country Healthcare Labcorp Quest Diagnostics DaVita Chemed CorVel Bausch + Lomb BrightSpring Health Services Amedisys (NASDAQ:AMED) and Pediatrix Medical Group (NYSE:MD) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership. Which has more volatility & risk, AMED or MD? Amedisys has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. Comparatively, Pediatrix Medical Group has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500. Does the media refer more to AMED or MD? In the previous week, Amedisys had 3 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 5 mentions for Amedisys and 2 mentions for Pediatrix Medical Group. Amedisys' average media sentiment score of 0.35 beat Pediatrix Medical Group's score of 0.33 indicating that Amedisys is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amedisys 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Pediatrix Medical Group 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer AMED or MD? Amedisys presently has a consensus target price of $100.75, indicating a potential upside of 4.80%. Pediatrix Medical Group has a consensus target price of $16.67, indicating a potential upside of 20.95%. Given Pediatrix Medical Group's stronger consensus rating and higher possible upside, analysts clearly believe Pediatrix Medical Group is more favorable than Amedisys.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amedisys 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25Pediatrix Medical Group 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is AMED or MD more profitable? Amedisys has a net margin of 3.79% compared to Pediatrix Medical Group's net margin of -4.17%. Pediatrix Medical Group's return on equity of 17.43% beat Amedisys' return on equity.Company Net Margins Return on Equity Return on Assets Amedisys3.79% 12.52% 7.01% Pediatrix Medical Group -4.17%17.43%6.35% Do institutionals and insiders believe in AMED or MD? 94.4% of Amedisys shares are held by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are held by institutional investors. 2.1% of Amedisys shares are held by insiders. Comparatively, 0.9% of Pediatrix Medical Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has higher earnings & valuation, AMED or MD? Amedisys has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmedisys$2.35B1.34$43.23M$2.7135.48Pediatrix Medical Group$2.01B0.59-$99.07M-$1.01-13.64 SummaryAmedisys beats Pediatrix Medical Group on 10 of the 16 factors compared between the two stocks. Get Pediatrix Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MD vs. The Competition Export to ExcelMetricPediatrix Medical GroupMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$1.18B$7.31B$5.56B$20.68BDividend YieldN/A2.78%5.22%3.71%P/E Ratio-13.6427.9427.6928.10Price / Sales0.5932.30386.4636.76Price / Cash7.8222.0136.8922.53Price / Book1.556.698.034.58Net Income-$99.07M$233.06M$3.18B$985.54M7 Day Performance-1.88%3.33%2.93%2.79%1 Month Performance-2.37%1.79%1.72%4.37%1 Year Performance102.35%37.40%34.39%15.08% Pediatrix Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDPediatrix Medical Group1.6439 of 5 stars$13.78flat$16.67+20.9%+102.5%$1.18B$2.01B-13.644,305AMEDAmedisys2.6984 of 5 stars$98.39+0.5%$100.75+2.4%-1.1%$3.23B$2.35B36.3119,000News CoverageAMNAMN Healthcare Services4.3028 of 5 stars$20.73-0.7%$32.08+54.8%-54.8%$793.54M$2.98B-4.792,968News CoverageAnalyst RevisionCCRNCross Country Healthcare3.8706 of 5 stars$13.05+2.0%$17.93+37.4%-3.4%$427.78M$1.34B-24.628,205News CoverageLHLabcorp4.4625 of 5 stars$262.39+0.7%$276.08+5.2%+28.0%$21.96B$13.01B30.3375,500Positive NewsInsider TradeDGXQuest Diagnostics4.9385 of 5 stars$179.52+1.0%$185.73+3.5%+27.3%$20.04B$9.87B22.7049,000News CoveragePositive NewsDVADaVita4.2855 of 5 stars$142.40+0.5%$164.50+15.5%+4.4%$10.75B$12.82B14.1176,000Positive NewsCHEChemed4.9685 of 5 stars$485.18-13.3%$645.00+32.9%-12.1%$7.10B$2.43B23.6315,695News CoverageAnalyst DowngradeHigh Trading VolumeCRVLCorVel1.0045 of 5 stars$102.78-0.8%N/A+19.4%$5.29B$895.59M55.965,075BLCOBausch + Lomb3.1096 of 5 stars$13.03+5.1%$15.54+19.3%-6.0%$4.61B$4.79B-12.6513,500High Trading VolumeBTSGBrightSpring Health Services1.4959 of 5 stars$23.59+0.2%$24.90+5.6%+98.5%$4.15B$11.27B84.2535,000Analyst Upgrade Related Companies and Tools Related Companies AMED Competitors AMN Competitors CCRN Competitors LH Competitors DGX Competitors DVA Competitors CHE Competitors CRVL Competitors BLCO Competitors BTSG Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MD) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s BIGGEST setup yet.After another undefeated quarter, “Market Wizard” Larry Benedict is sounding the alarm on a $194 trillion mark...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pediatrix Medical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pediatrix Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
